Market Place
Sourcing Support
Boundless Bio Announces Departure of Chief Financial Officer
14 Oct 2024 //
GLOBENEWSWIRE
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference
11 Sep 2024 //
GLOBENEWSWIRE
Boundless Bio Makes `Modest` Layoffs Amid Sluggish Enrollment
13 Aug 2024 //
FIERCE BIOTECH
Boundless Bio Reports Q2 2024 Results And Provides Business Updates
12 Aug 2024 //
GLOBENEWSWIRE
Boundless Bio: Participating At Goldman Sachs Healthcare Conference
05 Jun 2024 //
BUSINESSWIRE
Boundless Bio Reports Q1 2024 Financial Results, Highlights
13 May 2024 //
BUSINESSWIRE
Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024
06 May 2024 //
BUSINESSWIRE
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
01 May 2024 //
PR NEWSWIRE
Boundless Bio Doses First Patient With BBI-825 In Phase 1/2
11 Apr 2024 //
BUSINESSWIRE
Boundless Bio Presents Data at the AACR Annual Meeting 2024
08 Apr 2024 //
BUSINESSWIRE
Boundless Bio Announces Pricing of Initial Public Offering
27 Mar 2024 //
BUSINESSWIRE
Early-stage oncology startup Boundless Bio files for IPO
06 Mar 2024 //
ENDPTS
Boundless Bio bumps IPO market back to life
06 Mar 2024 //
FIERCE BIOTECH
Boundless Bio Announces Multiple Upcoming Presentations
05 Mar 2024 //
BUSINESSWIRE
Boundless Bio Presents Preclinical Data on the Discovery of BBI-825
13 Oct 2023 //
BUSINESSWIRE
Boundless Bio Announces Upcoming Presentations at 2023 AACR-NCI-EORTC
04 Oct 2023 //
BUSINESSWIRE
Boundless Bio Appoints New Board Members and Establishes Clinical Advisory Board
02 Oct 2023 //
BUSINESSWIRE
Boundless Announces Clinical Trial Collaboration and Supply Agreement with Lilly
19 Sep 2023 //
BUSINESSWIRE
Boundless Bio Announces Agreement with Taiho Oncology to Evaluate LYTGOBI
18 Sep 2023 //
BUSINESSWIRE
After EQRx stint,Jami Rubin quickly returns to CFO post at startup Boundless Bio
31 Jul 2023 //
ENDPTS
Boundless Bio snags $100M to enter clinic by targeting circular DNA bits
16 May 2023 //
ENDPTS
Boundless Bio Announces 1st Patient Dosed First-in-Human Ph1/2 Trial of BBI-355
09 May 2023 //
BUSINESSWIRE
Boundless Bio Presents Data on the Novel Discovery of CHK1 as an (ecDNA)
17 Apr 2023 //
BUSINESSWIRE
Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days
11 Apr 2023 //
BUSINESSWIRE
Boundless to Present at the 22nd Annual Needham Virtual Healthcare Conference
04 Apr 2023 //
BUSINESSWIRE
Boundless Bio Announces Upcoming Presentation at AACR Meeting
15 Mar 2023 //
BUSINESSWIRE
Boundless Bio to Participate at Two Upcoming Investor Conferences
15 Nov 2022 //
BUSINESSWIRE
Boundless Bio Appoints Sara Weymer as Vice President, Clinical Operations
03 Jun 2022 //
BUSINESSWIRE
Boundless Bio Announces Upcoming Presentation at AACR 2022
09 Mar 2022 //
BUSINESSWIRE
Boundless Bio to Present at the Oppenheimer 32nd Annual Healthcare Conference
08 Mar 2022 //
BUSINESSWIRE
Boundless Bio lures Berkley from Ionis to support clinical push
08 Feb 2022 //
FIERCEBIOTECH
Boundless Bio Appoints Peter Krein, Ph.D., as Vice President, Precision Medicine
17 Jan 2022 //
BUSINESSWIRE
Boundless Bio to Present at Piper Sandler & Evercore ISI HealthCONx Conference
17 Nov 2021 //
BUSINESSWIRE
Boundless Bio Appoints Jessica Oien as General Counsel and Corporate Secretary
30 Aug 2021 //
BUSINESSWIRE
Boundless Bio Appoints Neil Abdollahian as Chief Business Officer
09 Aug 2021 //
BUSINESSWIRE
Boundless Bio Announces Upcoming Presentation at the American Association
31 Mar 2021 //
BUSINESSWIRE
Boundless Bio Appoints Shailaja Kasibhatla as VP, D & T Development
18 Mar 2021 //
BUSINESSWIRE
